Results 111 to 120 of about 16,129 (156)

Progressive Supranuclear Palsy with Predominant Speech/Language Disorder. [PDF]

Intern Med
Maeshima S, Sakurai K, Osawa A, Arai H, Takeda A.   +4 more
europepmc   +1 more source

Diagnostic utility of biomarkers in progressive supranuclear palsy: toward a biotyping framework. [PDF]

J Neurol
Ryan C, Camargo C, Salan T, Pallikkuth S, Gao H, Govind V.   +5 more
europepmc   +1 more source

Tongue strength in progressive supranuclear palsy. [PDF]

Parkinsonism Relat Disord
Clark HM, Stierwalt JA, Meade G, Ali F, Stephens Y, Botha H, Tosakulwong N, Weigand S, Josephs KA, Whitwell JL.   +9 more
europepmc   +1 more source

Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy. [PDF]

J Neurol
Lee S, Kim H, Kim R, Jin B, Kim S, Ha SH, Shin JH, Jeon B, Kim HJ, Lee JY.   +9 more
europepmc   +1 more source

Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy-Single-Center Study. [PDF]

Int J Mol Sci
Markiewicz M, Migda B, Otto-Ślusarczyk D, Madetko-Alster N, Wiercińska-Drapało A, Darewicz M, Struga M, Alster P.   +7 more
europepmc   +1 more source

Longitudinal monitoring of tau aggregation in progressive supranuclear palsy with [¹⁸F]PI-2620 PET. [PDF]

Alzheimers Dement
Gnörich J, Kusche-Palenga J, Palleis C, Neubauer A, Frontzkowski L, Jäck A, Kling A, Bauer T, Eyob H, Probst K, Roemer-Cassiano SN, Bernhardt AM, Katzdobler S, Marth L, Zaganjori M, Hopfner F, Zwergal A, Häckert J, Rullmann M, Sabri O, Barthel H, Stöcklein S, Werner RA, Simons M, Levin J, Herms J, Franzmeier N, Höglinger GU, Brendel M, German Imaging Initiative for Tauopathies (GII4T).   +29 more
europepmc   +1 more source

Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration. [PDF]

J Prev Alzheimers Dis
García-Castro J, VandeVrede L, Donohue MC, Vaqué-Alcázar L, Rubio-Guerra S, Selma-González J, Heuer HW, Morcillo-Nieto AO, Franquesa M, Dols-Icardo O, Bejanin A, Belbin O, Fortea J, Alcolea D, Carmona-Iragui M, Abdelnour C, Barroeta I, Santos-Santos M, Sánchez Saudinós MB, Sala I, Lleó A, Gorno-Tempini ML, Mandelli ML, Raman R, Wills AA, Barragan E, Litvan I, Boeve B, Dickerson B, Grossman M, Huey ED, Irwin DJ, Pantelyat A, Tartaglia C, Rojas JC, Boxer AL, Illán-Gala I, Four Repeat Tau Neuroimaging Initiative (4RTNI) and the AL108-231 Investigators.   +37 more
europepmc   +1 more source